IONIS PHARMACEUT reported $594.36M in Equity Capital and Reserves for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Agios Pharmaceuticals AGIO:US USD 1.05B 73.9M
Alnylam Pharmaceuticals ALNY:US USD -67638000 243.68M
Arrowhead Research ARWR:US USD 398.52M 55.41M
Astellas Pharma 4503:JP JPY 1.65T 110.47B
Biocryst Pharmaceuticals BCRX:US USD -242659000 29.43M
Biomarin Pharmaceutical BMRN:US USD 4.57B 63.71M
Bluebird Bio BLUE:US USD 158.86M 21.26M
Esperion Therapeutics ESPR:US USD -294100000 2.4M
Exelixis EXEL:US USD 2.49B 100.14M
Halozyme Therapeutics HALO:US USD 96.99M 196.18M
Intercept Pharmaceuticals ICPT:US USD 107.68M 477.51M
Mirati Therapeutics MRTX:US USD 1.13B 17.05M
Moderna Inc MRNA:US USD 17.99B 7M
Nektar Therapeutics NKTR:US USD 412.22M 46.51M
Neurocrine Biosciences NBIX:US USD 1.54B 121.2M
Novartis NOVN:VX USD 60.82B 2.1B
Omeros OMER:US USD -46314000 13.61M
Ptc Therapeutics PTCT:US USD -226904000 44.69M
Regeneron Pharmaceuticals REGN:US USD 21.44B 751M
Roche Holding ROG:VX 25.19B 700M
Sarepta Therapeutics SRPT:US USD 430.84M 295.62M
Ultragenyx Pharmaceutical RARE:US USD 468.83M 209.24M
Vertex Pharmaceuticals VRTX:US USD 13.03B 1.1B